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Abstract
Invasion through the extracellular matrix (ECM) is important for wound healing, immunological responses and metastasis.
We established an invasion-based cell motility screen using Boyden chambers overlaid with Matrigel to select for pro-
invasive genes. By this method we identified antisense to MARCKS related protein (MRP), whose family member MARCKS is
a target of miR-21, a microRNA involved in tumor growth, invasion and metastasis in multiple human cancers. We confirmed
that targeted knockdown of MRP, in both EpRas mammary epithelial cells and PC3 prostate cancer cells, promoted in vitro
cell migration that was blocked by trifluoperazine. Additionally, we observed increased immunofluoresence of E-cadherin,
b-catenin and APC at sites of cell-cell contact in EpRas cells with MRP knockdown suggesting formation of adherens
junctions. By wound healing assay we observed that reduced MRP supported collective cell migration, a type of cell
movement where adherens junctions are maintained. However, destabilized adherens junctions, like those seen in EpRas
cells, are frequently important for oncogenic signaling. Consequently, knockdown of MRP in EpRas caused loss of
tumorigenesis in vivo, and reduced Wnt3a induced TCF reporter signaling in vitro. Together our data suggest that reducing
MRP expression promotes formation of adherens junctions in EpRas cells, allowing collective cell migration, but interferes
with oncogenic b-catenin signaling and tumorigenesis.
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Introduction
Invasion of cells through the extracellular matrix (ECM) is a
complicated process involving migration by two alternating modes
of action with either cellular deformation allowing movement
through the ECM or by degradation of the ECM using factors such
as MMPs [1,2]. An established approach for assaying cellular
movement through the ECM is using Boyden chambers overlaid
with Matrigel, a basement membrane extract composed of
extracellular matrix. Though Matrigel lacks many of the important
attributes of endogenous basement membrane, such as less physical
cross-linking [3], it is frequently used to identify chemical factors
thateitherpromoteorinhibitinvasionofaparticularcelltype.Since
movement of cells through the extracellular matrix (ECM) is
necessary for normal physiological processes, such as wound healing
and movement of immune cells, in addition to pathological
processes, such as metastasis [4], we decided to establish an in vitro
invasion-based cell motility genetic screen.
Using the Boyden chamber assay with Matrigel we selected for
and identified antisense to MARCKS-related protein (MRP), a
member of the MARCKS family of proteins. MARCKS family
members have been implicated in actin cytoskeletal regulation, the
protein kinase C (PKC) signaling pathway and the calmodulin
(CaM) signaling pathway [5]. MARCKS family members have
strong affinity for calcium-calmodulin (Ca2+2CaM), but do not
bind to CaM [6,7]. Additionally they are abundantly expressed
making them a possible reservoir of Ca2+2CaM signaling [7,8].
Important to their regulation MRP and MARCKS are capable of
reversibly binding to the plasma membrane through the combina-
tion of their N-terminal myristoylation group and their effector
domain (ED). At the plasma membrane MARCKS/MRP are
thought to bind and sequester phosphatidylinositol bisphosphate
(PIP2) through the strongly basic ED. Phosphorylation of the ED by
protein kinaseC (PKC) prevents bindingofMARCKS/MRPto the
plasma membrane and to Ca2+2CaM. Binding of Ca2+2CaM to
the ED also prevents binding of MARCKS/MRP to the plasma
membrane and blocks phosphorylation by PKC. This mutual
exclusive relationship suggests that MARCKS family members
integrate PKC and CaM signaling [9,10]. Furthermore the
sequestration of PIP2 by MARCKS regulates accessibility to this
important signaling substrate [11]. Based on these interactions this
places MARCKS family members at the nexus of a number of
critical signaling pathways in cancer. Recently MARCKS was
shown to be a target of miR-21 a micro-RNA that promotes
invasionandmetastasisinanumberofhumancancersimplicatingit
as an important tumor suppressor [12]. In this report through an
invasion-based motility screen we identified MRP as affecting
adherens junction formation and tumorigenesis of EpRas cells.
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Tumor Cell Lines and Constructs
EpH4 and EpRas cells were maintained in complete media
(DMEM with 10%FBS). PC3, HeLa, HCT-116 and MCF-7 cells
were originally obtained from ATCC and maintained in complete
media. EpRas cells were obtained from Martin Oft (Schering-
Plough Biopharma, Palo Alto, California). Pooled stable cell lines
were selected in 3 mg/mL puromycin for two weeks after EpH4
cells were transfected with either p-Babe-puro or p-Babe-puro-
asMRP. EpRas clonal lines were selected in 3 mg/mL puromycin
for two weeks after transfection with control shRNA or shRNAs to
human and mouse MRP (Open Biosystems), colonies were picked
and maintained in media with puromycin. To make the p-Babe-
puro-asMRP construct an EcoRI containing asMRP fragment of
pEyk3.1-asMRP isolated from the screen was subcloned into the
EcoRI site of p-Babe-puro.
Real Time Quantitative PCR and Northern
MRP mRNA expression as assessed by Northern analysis using
P
32 59-labeled DNA probes to MRP and GAPDH by methods
previously described [13], quantitated with STORM phosphor-
imager and normalized to GAPDH. MRP mRNA levels were
analyzed by qt-PCR using SYBR green and normalized to actin.
qt-PCR was performed using primer pairs (TTCTTTTCCAAG-
TAGGTTTTGTTTACC and CACTCAAGGTTTGGGAGTA-
TAAGCA) for MRP and primer pairs (GCCAACCGC-GAGAA-
GATGA and CATCACGATGCCAGTGGTA) for actin.
Retroviral Generation and Infections
Procedures were followed as described in greater detail in Koh
et. al. [14]. Briefly 293T cells were transfected at a 1:1 ratio of the
retroviral construct to the packaging construct PCL-eco using
FuGENE6 (Roche). The medium was changed 16 hours after
transfection. At 30 hours after transfection, supernatants were
isolated and cells were spin infected with 8 mg/ml of polybrene
(Sigma).
Cell Migration and Invasion-Based Motility Assay
Invasion-based motility assays and screen were performed with
BD BioCoat Matrigel invasion chambers (BD Biosciences). Cell
migration assay was performed using 8.0-mm pore size 96-well MIC
Transwell plates (Millipore). For both procedures cells were serum-
starved overnight, harvested with TrypLE Express (Invitrogen), and
washed twice with serum-free DMEM. Cells were then re-
suspended in DMEM and were added to the upper chamber while
the lower chamber was filled with complete media as a
chemoattractant. After 16 hours at 37uC, the cells on the upper
surface of the membrane were removed by cotton tips. For the
screen, cells were harvested using TrypLE Express and cell scraping
then allowed to recover in complete media for 48 hours prior to
additional rounds of selection. For migration and invasion-based
motility assay, cells attached to the lower surface were fixed in ice-
cold methanol for 10 minutes, and stained for 10 minutes with a
solution containing 0.5% crystal violet and 2% ethanol in 100 mM
borate buffer (pH 9.0). The number of migrated cells on the lower
surface of the membrane was counted under a microscope in five
fields (1006). For wound healing assay cells were plated onto
35 mm gridded dishes (Ibidi). Confluent cells where wounded with
100 uL tip and monitored for migration into the wound.
Luciferase Reporter Assay
Indicated cells were plated onto 12-well plates and transfected
with 400 ng TOPFLASH (Millipore) b-catenin reporter construct
with firefly luciferase and as a transfection control, 100 ng pRL-
CMV (Promega) construct with renilla luciferase. Cells were
treated with Wnt3a (R&D systems) for 24 hours starting 24 hours
after transfection. Luciferase was assayed using dual-luciferase
reporter assay system (Promega) on a TD-20/20 luminometer
(Turner Biosystems) using manufacturer instructions.
Tumor and Tail Vein Metastasis
EpRas cells were injected intravenously with 5610
5 cells in
0.1 ml PBS via tail veins or subcutaneous. All tissue was fixed in
buffered formalin and than store in 70% ethanol. After washing
with fresh PBS, fixed tissues were dehydrated, cleared, and
embedded in paraffin. Sections (5 mm) were collected on
microscope slides, deparaffinized, and stained with H & E as
routine procedures.
Western Blots and Immunofluoresence
For immunofluoresence, cells were plated on glass cover slips,
serum starved overnight, formaldehyde fixed and permeabilized
with methanol for immunofluorescence and imaged at 100X oil-
immersion. Cells were incubated with primary antibodies to E-
cadherin (Becton Dickinson), APC (Calbiochem) or b-catenin
(Becton Dickinson) and secondary antibodies Alexa fluor 488 anti-
rabbit or anti-mouse (Invitrogen). For western blots, cells were
lysed was with MPER (Pierce) and run on SDS-Page immuno-
blotted with antibodies to Ras (Cell Signaling), E-cadherin (Becton
Dickinson), b-catenin (Becton Dickinson), or c-tubulin (Sigma),
followed by secondary mouse or rabbit HRP (Amersham
Biosciences).
Statistical Analysis
Data were expressed as mean6SD. Student’s t-test was used to
evaluate the difference between two groups. P,0.05 was
considered to be significant.
Results
An Invasion-Based Motility Screen Identifies Antisense to
MRP
We established a novel strategy to select for genes that promote
in vitro motility through Matrigel, a basement membrane extract
composed of extracellular matrix. For our screen the immortalized
mouse mammary cell line EpH4 was chosen to better reflect
normal mammary epithelial cells. We transiently transfected 293
cells with a pEyk3.1 retroviral cDNA library made from mRNA
isolated from mouse embryos or a control pEyk3.1 retrovirus
containing EGFP [14]. We harvested viral supernatant from the
293 cell cultures and infected 6610
6 EpH4 cells with either the
library or EGFP retroviral particles. Both library and EGFP
infected EpH4 cells were screened in parallel. The selection
protocol involved plating cells starved for 18 hours onto Boyden
chambers overlaid with Matrigel. We then allowed cells to invade
overnight using complete media as a chemoattractant. Invasive
cells were harvested, plated in complete media and recovered for
48 hours before another round of selection (Fig. 1a). After three
rounds of selection we observed an increase in library infected cells
over control, therefore cells were harvested, clonally grown and
analyzed by genomic PCR for retroviral integrants (Fig. 1b). This
analysis revealed 49 out of 500 positive clones.
To confirm promotion of migration each of the 49 clones were
individually transfected with a pCL-Eco helper plasmid for
repackaging retroviral integrants and subsequent infection of
naı ¨ve EpH4 cells (Fig. 1c). Newly infected EpH4 cells were then
submitted to the same Boyden chamber assay used in the screen.
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fold above mock-infected cells (Fig. 1c) suggesting at least a subset
of genes was conferring increased movement through Matrigel.
The genes identified in the two positive clones were antisense to
Marcks-related protein (MRP), C-terminally truncated potassium
channel KCC4 (ctKCC4) and antisense to ODC-AZ (asODC-
AZ).
Since we observed multiple retroviruses transferring into the
naı ¨ve EpH4 cells, we tested each individually to determine which
were responsible for increased migration through Matrigel. To
determine this asMRP, ctKCC4 or asODC-AZ were individually
cloned downstream of the chicken beta-actin promoter into the
puromycin resistance carrying pBabe-puro vector. After selection
under puromycin we tested these pooled stable cell lines for
increased movement through Matrigel, identifying antisense to
MARCKS related protein (asMRP) as conferring approximately a
five-fold increase in migration and invasion in comparison to
pBabe control pooled stables (Fig. 1d).
MRP-shRNA Induces Migration in EpRas Cells
Since EpH4 cells are a non-tumorigenic cell line we were
interested in using the tumorigenic v-HA-Ras transformed EpH4
cells (EpRas) for in vivo studies and we chose to knockdown gene
expression with MRP shRNA. Parental EpRas cells, control
EpRas, which had undergone clonal selection with puromycin
after transfection with shRNA to GFP (C1), or shRNA targeted
knockdown of MRP and clonal selection by puromycin (E13, E14)
were tested for loss of MRP expression by Northern blot analysis.
MRP mRNA expression of control (C1) cells was 80%, EpRas13
(E13) clone was 33% and EpRas14 (E14) clone was 20% of
parental EpRas cells (Fig. 2a and b). When normalized to
migration of EpRas both E13 and E14 showed 2-fold or greater
Figure 1. Isolation of antisense to MRP in Invasion-based motility screen. a) Schematic of ECM screen. b) Representative genomic PCR of
isolated clones for inserts in pEyk3.1, Ld= 1 kb ladder (NEB). c) To segregate multiple retroviral integrants, retrovirus was repackaged from either
invading clones or the control EGFP clones using pCL-Eco helper plasmid (top schematic). Naive EpH4 cells were infected and individual clonal lines
were assayed for invasion. The two most invasive clones were determined to have both been infected with antisense to MRP (dark grey). d) Mouse
mammary cell line EpH4 was stably transfected with expression pb plasmid containing antisense MRP identified in the screen or control plasmid and
subjected to invasion or migration assays. Data is mean of three independent experiments 6 SD. * is p,0.01
doi:10.1371/journal.pone.0007833.g001
Invasion Screen Identifies MRP
PLoS ONE | www.plosone.org 3 November 2009 | Volume 4 | Issue 11 | e7833increase in migration (Fig. 2b). We also used a wound-healing
assay to test the effects of targeted knockdown on migration. Both
E13 and E14 had faster wound healing with cells showing
collective migration into the wound, while EpRas and C1 had
delayed migration with cells loosely associating (Fig. 2c and Fig.
S1). Single cell migration is a well-studied mode by which cells
invade their surroundings and frequently cancer cells acquire this
ability through mechanisms such as epithelial-mesenchymal
transition (EMT). However less understood is collective cell
migration where cells move without loss of cell-cell attachments.
Collective cell migration is frequently observed in many invasive
tumors and is developmentally important for organogenesis
[15–17]. By both migration assays, reduced MRP increased
migration of EpRas cells. The wound-healing assay also implicates
a role in collective migration, since cell-cell associations did not
impede migration.
MRP-shRNA Increased In Vitro Migration That Is Blocked
by TFP
Three possible methods of regulating migration by MRP are the
direct regulation of the cytoskeleton through actin, sequestration of
PIP2 and thereby regulating PKC mediated cell migration and
lastly, functioning as a reserve for Ca2+/CaM and therefore
regulating its control of migration [7,8]. To determine which of
these pathways is promoting migration in EpRas cells we used
inhibitors to PI-3K (Ly294002), PKC (bisindolylmaleimide),
calcineurin (Cyclosporin A), and calmodulin (trifluoperazine) as
well as an activator of PKC (Phorbol 12-myristate 13-acetate).
Only the CaM inhibitor trifluoperazine (TFP) reduced migration
of E13 and E14 to EpRas migration levels while not appreciably
affecting the migration of EpRas or C1 (Fig. 3a). This suggests that
the calmodulin (CaM) pathway may be important for MRP
knockdown induced migration in EpRas cells. One cautionary
note is the effect of calmodulin inhibitors, such as TFP, on
electrostatic surface potential, which could interfere with multiple
pathways in addition to calmodulin [18].
To determine if MRP knockdown would also promote migration in
other cell lines we transiently transfected a panel of human cancer cell
lines with two different human shRNAs to MRP or control shRNA to
GFP. We tested the colon cancer line HCT-116, the cervical
carcinoma line HeLa, the mammary adenocarcinoma MCF-7, and
the prostate cancer line PC3. In our Boyden migration assay serum
containing media was used as a chemoattractant and PMA was added
as a positive control to demonstrate poorly migrating cells were
competent for migration. PC3 cells showed an approximate 12-fold
increase in migration when transiently transfected with shRNAs to
MRP, which was not improved by addition of PMA (Fig. 3b). By
quantitative PCR we showed an approximate 50% reduction of MRP
mRNA levels in all four cell lines tested 48 hours after transient
transfection with MRP shRNA 1 or 2 (Fig. 3c and d). We also
determined differences in MRP expression between the cell lines and
noted that PC3 has the lowest starting level of MRP, being 60% of
HCT-116 levels and 50% or less of HeLa and MCF-7 (Fig. 3d). We
Figure 2. Targeted knockdown of MRP in EpRas promotes migration. a) Parental EpRas cells, clonal cell lines stably transfected with control
shRNA (C1) or with shRNA (Open Biosystems) directed to mouse MRP (E13, E14). a) and left panel of b) Quantified MRP mRNA expression as assessed
by Northern blot analysis and normalized to GAPDH (Northern shown). Right panel of b) The cell lines were assayed for transwell migration and
normalized to EpRas, * is p,0.01 c) Confluent cells of C1 and E13 were assayed for migration into wound at 0, 6, and 18 hours after wounding. Note
migration from left grid line as reference. Representative of three experiments.
doi:10.1371/journal.pone.0007833.g002
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determine what pathway was mediating the migration of PC3 cells.
Unlike EpRas cells other inhibitors showed modest but not statistically
significant reduction in PC3 migration induced by shRNA to MRP.
However similar to EpRas cell, PC3 cells transfected with shRNA to
MRP were most strongly inhibited by TFP (Fig. 3e).
Loss of MRP Causes Establishment of Adherens Junctions
and Reduced b-Catenin Signaling
EpRas cells with MRP knockdown (E13, E14) showed increased
cell clustering suggesting establishment of adherens junctions
(Fig. 4a). When directly comparing cells in clusters, we observed an
increased immunofluoresence for the adherens junction markers
E-cadherin, APC and b-catenin in MRP-knockdown cells at sites
of cell-cell contact (Fig. 4b). We wanted to determine if E-cadherin
levels were affected by changes in adherens junctions so we
analyzed by western blot the expression levels of both E-cadherin
and b-catenin, observing increased E-cadherin expression but no
changes in b-catenin in MRP-knockdown cells (Fig. 4c). We next
wanted to determine if formation of adherens junctions would
affect b-catenin signaling since catenins are known to interact with
the cytoplasmic domain of E-cadherins at sites of adherens
Figure 3. Effects of MRP targeted knockdown on migration is blocked by trifluoperazine. a) Parental EpRas cells, C1, E13 and E14 were
assayed for transwell migration with or without chemical inhibitors (Ly294002 50 mM, Bis 1 mM, CSA 10 ug/mL, TFP 50 mM, PMA 100 ng/mL). The
number of cells that migrated to the bottom of the transwell after 16 hours were counted and normalized to control, * is p,0.05 b) Indicated human
cell lines were tranfected with shRNA to GFP (C) or two different shRNAs (1,2) to human MRP (Open Biosystems) and analyzed by transwell assay, * is
p,0.01. c,d) MRP mRNA levels were analyzed by qt-PCR and normalized to actin after transfection with control shRNA or shRNAs to human MRP (1,2)
(c) or basal MRP mRNA levels (d). e) PC3 cells were transfected with shRNA1 or 2 and analyzed as in (a), * is p,0.05. All data is mean of three
independent experiments 6 SD.
doi:10.1371/journal.pone.0007833.g003
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signaling, b-catenin binds to TCF-LEF-1 family of transcription
factors to activate gene expression [19]. We used the TCF-
luciferase reporter TOPFLASH to assess the role of MRP in b-
catenin signaling. While E13 and E14 show a two-fold induction of
reporter activity, an approximate 12-fold induction was seen for
both EpRas and C1 in response to Wnt3a (Fig. 4d).
Loss of MRP Causes Loss of Tumorigenecity
An increase in adherens junctions and reduced b-catenin
signaling could interfere with tumor progression, however the
effects of reduced MRP on cellular invasion may increase local
invasion and metastasis. We carried out experiments to determine
the effects of reduced MRP on both tumorigenesis and metastasis
since no previous in vivo cancer studies had been performed with
MARCKS family members. For both subcutaneous and tail vein
injections we injected 5610
5 of EpRas, C1, 13 or 14. Cumulative
of two independent experiments both EpRas and C1 showed rapid
subcutaneous tumor development with ten out of ten mice for
EpRas having average tumor weights of 1.4 grams and six out six
mice for C1 having an average of 1.25 grams for C1 by 4 weeks,
while no tumors out of ten mice grew out for E14 and only one out
of ten mice developed a tumor in the E13 (Fig. 5a). The single E13
tumor required 12 weeks to achieve 0.5 gram and the mouse was
sacrificed at this smaller tumor size due to ulceration at the tumor
site. Histological analysis of the lungs and livers of all the animals
Figure 4. Targeted knockdown of MRP leads to establishment of adherens junctions. a) Bright field imaging of EpRas, C1, E13, and E14 at
10X. b) EpRas, C1, E13 or E14 cells were stained with primary antibodies specific to either E-cadherin (Becton Dickinson), APC (Calbiochem) or b-
catenin (Becton Dickinson) and secondary antibodies Alexa fluor 488 anti-rabbit or anti-mouse (Invitrogen). Images at 100X c) Western blot analysiso f
EpRas, C1, E13, E14 whole cell lysates and immunoblotted with antibodies to Ras (Cell Signaling), E-cadherin and b-catenin (Becton Dickinson), and c-
tubulin (Sigma). NS= non-specific. d) Indicated cells transfected with the TCF luciferase reporter construct TOPFLASH and transfection control pRL-
CMV were treated with 0, 50 ng/mL or 100 ng/mL of recombinant WNT3a for 18 hours. All data is mean of three independent experiments 6 SD.
doi:10.1371/journal.pone.0007833.g004
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injections, again as cumulation of two independent experiments,
ten mice were injected per cohort with EpRas and C1 showing
aggressive tumor numbers and size in the lungs while E13 and E14
had far fewer tumors. The mets that did develop for E13 and E14
were much smaller in size when mice were sacrificed 4 weeks after
tail vein injections as represented in Figure 5b. We were concerned
that the observed loss of tumorigenecity could be due to loss of the
transforming v-HA-Ras during clonal selection. Western blot
analysis revealed no obvious difference in either endogenous or v-
HA-Ras expression between the parental EpRas, C1, E13 or E14
(Fig. 4c). Based on the failure of subcutaneous tumors to grow, the
greatly reduced number of metastasis observed in the MRP
knockdown clones is likely a consequence of lost tumorigenecity.
Discussion
Our data suggest that knockdown of MRP promotes adherens
junction formation. A possible route that MRP could regulate
adherens junction formation is through its regulation of calmod-
ulin (CaM) via the scaffolding protein IQGAP. MRP is known to
bind to Ca2+/CaM with nanomolar affinity, but does not bind to
CaM [6,7]. IQGAP, which is regulated by Ca2+/CaM is
important for controlling cell migration and adherens junction
formation [20,21], making it a possible downstream effector of
MRP. Alternatively, in Drosophila a novel pathway to adherens
junction formation was identified. It involved localization of a
synaptotagmin-like protein Btsz to PIP2. Btsz binds PIP2 and
increases adherens junction formation through stabilization of E-
cadherin. In this system decreasing PIP2 levels blocked adherens
junction formation [22]. Interestingly, MARCKS family members
regulate accessibility to PIP2 and any reduction in their expression
could promote adherens junction formation through this pathway.
Whatever may be the case identifying how MRP regulates
adherens junction formation is an important next step.
Regulation of adherens junction is also important for controlling
tumorigenesis. It has previously been shown that the introduction
of wild type APC into the colorectal cancer cell line SW480, which
Figure 5. Loss of tumorigenesis with targeted knockdown of MRP. 5610
5 cells EpRas cells, clonal cell lines stably transfected with control
shRNA (C1) or with shRNA directed to MRP (E13, 14) were injected subcutaneously into five congenic Balb/c mice per cohort (a) or into 10 mice per
cohort by tail vein injection (b). Tumor weight was assessed at the indicated times. Representative H&E staining of lung sections from each group at
46magnification (b).
doi:10.1371/journal.pone.0007833.g005
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proteins b-catenin and E-cadherin to the plasma membrane and
inhibited SW480 tumorigenesis [23] similar to what we observed
with reduced MRP. Other groups have shown the converse with
disruption of adherens junction promoting tumorigenesis and
metastasis [24]. These studies all implicate b-catenin signaling as
important in tumorigenesis and our data suggest reduced MRP
can lead to reduced b-catenin signaling. In cancer, frequently
mutations arise that lead to disruption of adherens junctions, such
as loss of APC, loss of E-cadherin or mutationally activated b-
catenin. It is possible that reduced MRP would promote metastasis
without interfering with tumorigenesis in such instances. Using cell
lines that are not dependent on the b-catenin pathway for
transformation may allow modeling the role of MRP knockdown
in cancer invasion and metastasis, in vivo.
Our results are somewhat counterintuitive having proteins that
promote migration while also promoting adherens junction
formation. However this is exactly what occurs with collective
migration. For invasion and metastasis both individual and
collective migration of cancer cells is observed, with epithelial-
mesenchymal transition (EMT) being a common mechanism for
individual cell migration, while the mechanisms for collective
migration are poorly understood [1,25]. Prodoplanin, a mucin-like
protein found at the leading edge of multiple tumor types, induces
tumor cell invasion in the absence of epithelial-mesenchymal
transition (EMT) by increasing collective cell migration [26].
Additionally, in the squamous cell carcinoma cell line A431,
siRNA to p120-catenin caused loss of adherens junctions but also a
75% reduction in cell invasion. It was established that the cells
invaded collectively, which was only possible with p120 mainte-
nance of adherens junctions. Interestingly, squamous cell carcino-
ma of the head and neck also appears to invade collectively in
clinical samples [27]. The importance of collective cell migration
in metastasis is becoming of increasing interest and exploration of
MARCKS family members in collective cell invasion should be
further explored. Additionally MARCKS family members may
provide insight into how initiation of cancer and its maintenance
differs between metastatic cancers that display collective cell
migration behavior and those that undergo EMT. Overall, in this
study we established a novel invasion-based cell motility screen
identifying MRP and showing its importance in migration,
transformation and adherens junction formation.
Supporting Information
Figure S1 Confluent cells of EpRas,C1, E13, and E14 were
assayed for migration into wound at 0, 6, and 18 hours after
wounding.
Found at: doi:10.1371/journal.pone.0007833.s001 (8.79 MB TIF)
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